16S Next Generation Sequencing (16S NGS): The New Era in Gut Microbiome Analysis

Gut Microbiome Analysis Is Evolving

In recent years, the gut microbiome has emerged as one of the most important factors influencing human health. Thousands of scientific publications have linked its composition and function to processes such as metabolism, immune regulation, intestinal barrier integrity, and communication between the gut and the brain.

Alongside advances in scientific knowledge, the laboratory technologies used to study the microbiome have also evolved significantly. Modern approaches are no longer limited to detecting a small number of specific microorganisms. Instead, the goal is to understand the microbial ecosystem as a whole, including its structure, diversity, and functional dynamics.

This transition has been made possible by the development of 16S Next Generation Sequencing (16S NGS) technology and advanced bioinformatics methods. Today, these technologies enable the simultaneous analysis of thousands of different microbial species and transform complex sequencing data into clinically meaningful information.

This evolution represents a fundamental shift in the way we approach the gut microbiome. The question is no longer simply "Which bacteria are present?" but rather "How is the microbial ecosystem organized, and what functions does it appear to support?"

The Gut Microbiome and Why Studying It Matters

The gut microbiome consists of trillions of microorganisms, primarily bacteria, that naturally inhabit the human gastrointestinal tract. It is an extraordinarily complex ecosystem in which hundreds to thousands of different species interact not only with one another but also with their human host.

The activity of this ecosystem influences numerous biological processes. Among other functions, the gut microbiome contributes to:

• the breakdown of dietary components that cannot be digested by human enzymes,
• the production of metabolites that influence intestinal physiology,
• the maintenance of microbial ecosystem balance,
• interactions with the immune system,
• communication between the gut and the brain through complex metabolic and immunological pathways.
   

It is becoming increasingly clear that the function of the microbiome does not depend on the presence of a single "beneficial" or "harmful" bacterium. Instead, it reflects the collective activity of hundreds of different microorganisms that together form a dynamic and continuously changing ecosystem.

For this reason, microbiome assessment is shifting away from the simple identification of individual microbial species toward a comprehensive evaluation of the ecological balance and functional behavior of the intestinal microbial ecosystem.

How Microbiome Analysis Has Evolved

Until just a few years ago, the study of the gut microbiome relied primarily on detecting specific microorganisms already known to be associated with human health. The underlying concept was relatively straightforward: researchers or clinicians selected a number of bacteria considered important, and the laboratory determined whether these microorganisms were present in the sample and, if so, in what quantity.

This approach continues to provide significant clinical value in many situations. For example, when there is suspicion of a specific pathogenic microorganism or when precise quantification of a well-established beneficial bacterium is required, targeted molecular techniques remain highly reliable diagnostic tools.

However, as microbiome research advanced, it became increasingly evident that gut function cannot be explained solely by the presence or absence of individual microorganisms.

Two individuals may have similar levels of a particular bacterium while exhibiting entirely different overall microbiome compositions and, consequently, distinct functional profiles. Likewise, relatively small changes across dozens or even hundreds of microbial species may substantially influence the overall behavior of the ecosystem, even when no single microorganism displays a particularly striking change on its own.

In other words, the focus of the scientific community has gradually shifted from "Which bacteria are present?" to "How does the microbial ecosystem function as a whole?"

This conceptual shift is arguably the most important development in microbiome research over the past decade and has created the need for new technologies capable of analyzing not just selected microorganisms, but the entire bacterial community.

From Studying Individual Bacteria to Mapping the Entire Ecosystem

The term "microbiome mapping" is frequently used in today's scientific literature, and for good reason. Just as a geographical map depicts not only individual locations but also the relationships between them, modern microbiome analysis seeks to capture the overall architecture of the bacterial ecosystem rather than simply identifying isolated microorganisms.

A simple analogy helps illustrate this change in perspective.

Imagine trying to evaluate the condition of an entire city by observing only three or four buildings. Even if you know every detail about those buildings, it would be difficult to gain a comprehensive understanding of how the city actually functions.

In contrast, if you have access to a complete map, you can appreciate the layout of neighborhoods, their connectivity, areas of high activity, and the overall organization of the urban environment.

The same principle applies to the gut microbiome.

The presence of a particular microorganism represents only a small part of the overall picture. Its true biological significance emerges from the way hundreds of different microbial species coexist, interact, and collectively shape a dynamic ecosystem.

For this reason, modern microbiome analysis seeks to answer questions such as:

• How diverse is the microbial community?
• How evenly are the different microbial species distributed?
• What functional capabilities does the microbial ecosystem appear to possess?
• What ecological or metabolic patterns emerge from their overall composition?
   

These questions cannot be answered by analyzing only a limited number of selected bacteria. They require the most comprehensive possible mapping of the bacterial community together with advanced analytical tools capable of interpreting these complex datasets. This is precisely what 16S Next Generation Sequencing (16S NGS) technology makes possible.

What Is 16S Next Generation Sequencing (16S NGS)?

16S Next Generation Sequencing (16S NGS) is a modern molecular technology that enables comprehensive analysis of the entire bacterial community within a sample, without requiring the microorganisms of interest to be predefined in advance.

The technology is based on sequencing the 16S rRNA gene, a gene found in virtually all bacteria. This gene contains regions that are highly conserved across bacterial species, as well as variable regions that differ from one species to another. This unique combination enables the identification and classification of the diverse bacterial species present in a sample.

After microbial DNA is extracted from the stool sample, hundreds of thousands to millions of DNA fragments are sequenced. Specialized bioinformatics algorithms then compare these sequences with international reference databases and calculate the relative abundance of the bacterial groups that make up the gut microbiome.

Unlike targeted molecular assays, this technology is not limited to detecting a predefined set of microorganisms. Instead, it provides a far more comprehensive overview of the bacterial community, forming the foundation for subsequent ecological and functional assessment of the gut microbiome.

PCR and 16S NGS: Two Different Approaches, Two Different Objectives

The comparison between Real-Time PCR and 16S NGS is often presented as a competition between an "older" and a "newer" technology. In reality, however, these are two distinct approaches designed to answer different clinical questions.

Real-Time PCR is a targeted molecular technique. The laboratory knows in advance which microorganism it intends to detect and uses specific primers to identify its genetic material. This approach offers high sensitivity and accuracy when the objective is to confirm the presence or precisely quantify a specific microorganism.

By contrast, 16S NGS does not begin with the question, "Is bacterium X present?" Instead, it addresses a much broader question: "What is the overall composition of the bacterial community?" Rather than examining a limited number of predefined microorganisms, it gathers information from the entire bacterial ecosystem and generates a detailed profile of the relative abundance of the different bacterial taxa.

This does not mean that one method replaces the other. The appropriate choice always depends on the clinical question being addressed.

For example:

• when there is suspicion of a specific infection or precise quantification of a known microorganism is required, targeted molecular techniques represent the most appropriate choice;
• when the objective is a comprehensive evaluation of the microbiome's structure and functional dynamics, 16S NGS can provide substantially broader information.
   

In other words, these two approaches are not competing technologies. Rather, they are complementary tools that can be used according to the specific clinical question being investigated.

From DNA Sequencing to Clinically Meaningful Information

The ability to analyze millions of DNA sequences represents a remarkable technological achievement. However, sequencing alone is not sufficient to generate clinically meaningful information.

A single microbiome sample may contain hundreds of different bacterial species, each present at a different relative abundance. Simply providing a long list of microorganisms, even if highly accurate,is of limited value in everyday clinical practice.

The real challenge, therefore, lies not only in generating the data but, more importantly, in interpreting it.

This is where bioinformatics plays a pivotal role. Using specialized computational tools, sequencing data are organized, analyzed, and integrated to reveal not only which bacteria are present, but also how the microbial ecosystem is structured as a whole.

This approach makes it possible to derive insights that go far beyond the simple identification of microorganisms. It lays the foundation for developing indices and analytical models that describe ecological balance, potential functional trends, and the overall behavior of the gut microbiome.

Why 16S NGS Is Changing the Philosophy of Microbiome Analysis

In summary, 16S Next Generation Sequencing (16S NGS) is not simply another laboratory method or a newer sequencing technology. It represents a fundamentally different way of studying the gut microbiome.

In the past, the primary focus was detecting specific microorganisms. Today, however, scientific evidence demonstrates that microbiome function depends on a far more complex network of interactions. What matters is not only which bacteria are present, but also how they coexist, interact, and collectively shape a dynamic microbial ecosystem.

The ability to map the entire bacterial community, combined with modern bioinformatics approaches, enables a more comprehensive evaluation of the gut microbiome. Rather than focusing solely on individual microorganisms, this modern analytical strategy seeks to identify ecological patterns, functional relationships, and characteristics that describe the microbiome as an integrated ecosystem.

This evolution is transforming not only the technology itself but also the way microbiome data are interpreted, creating new opportunities to support scientific research and, progressively, more personalized clinical assessment.

Over the coming years, the primary challenge will no longer be generating larger volumes of sequencing data, but rather transforming these data into meaningful information that healthcare professionals can apply in clinical practice. Already, the development of advanced computational tools and increasingly sophisticated bioinformatics methodologies is enabling the extraction of far richer insights from microbiome analyses, gradually shifting the focus from individual bacterial species toward a deeper understanding of the overall function of the microbial ecosystem.

This evolution represents one of the most exciting frontiers of modern biomedical research and is expected to shape the future of microbiome analysis in the years ahead.

References

1. McCallum, G., Tropini, C. The gut microbiota and its biogeography. Nat Rev Microbiol 22, 105–118 (2024). https://doi.org/10.1038/s41579-023-00969-0
2. Filardo S, Di Pietro M and Sessa R (2024) Current progresses and challenges for microbiome research in human health: a perspective. Front. Cell. Infect. Microbiol. 14:1377012. doi: 10.3389/fcimb.2024.1377012
3. Regueira-Iglesias A, Balsa-Castro C, Blanco-Pintos T, Tomás I. Critical review of 16S rRNA gene sequencing workflow in microbiome studies: From primer selection to advanced data analysis. Mol Oral Microbiol. 2023;38(5):347-399. doi:10.1111/omi.12434
4. Fox, J. D., Sims, A., Ross, M., Bettag, J., Wilder, A., Natrop, D., Borsotti, A., Kolli, S., Mehta, S., Verma, H., Kurashima, K., Manithody, C., Verma, A., & Jain, A. (2024). Bioinformatic Methodologies in Assessing Gut Microbiota. Microbiology Research, 15(4), 2554-2574. https://doi.org/10.3390/microbiolres15040170

At Diagnostiki Athinon, we treat prevention with the seriousness it deserves. This is where science meets personalized care.